Product
Dihydroartemisinin-Piperaquine
Aliases
Artekin, D-Artepp, Dihydroartemisinin-Piperaquine (DP), DP (3 other aliases)
6 clinical trials
4 indications
Indication
MalariaIndication
Malaria in PregnancyIndication
Pregnancy RelatedIndication
AnemiaClinical trial
Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)Status: Completed, Estimated PCD: 2020-12-16
Clinical trial
Evaluation of the Efficacy of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in Children With Uncomplicated Clinical Malaria in Rural RwandaStatus: Completed, Estimated PCD: 2023-12-08
Clinical trial
Intermittent Preventive Treatment in Pregnancy With Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine to Prevent Malaria Infection and Reduce Adverse Pregnancy Outcomes in Papua New Guinea - a Randomised Controlled TrialStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, MalawiStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy: a Longitudinal StudyStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Clinical Trial to Evaluate Intermittent Screening and Treatment and Intermittent Preventive Treatment of Malaria in Asymptomatic Schoolchildren to Decrease P. Falciparum Infection and Transmission: Phase 2 Comparing Drug RegimensStatus: Completed, Estimated PCD: 2023-07-28